MediPharm Labs (LABS) Stock Chart & Stock Price History → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free LABS Stock Alerts C$0.08 +0.01 (+6.67%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades MediPharm Labs Stock Price Performance5 Day Performance0.00%1 Month Performance0.00%3 Month Performance+14.29%6 Month Performance+14.29%Year-To-Date Performance+23.08%1 Year Performance+14.29% Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company LABS Stock Chart for Monday, May, 20, 2024 LABS Chart by TradingView MediPharm Labs Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024C$0.08C$0.08+6.67%C$0.09C$0.08373,738 shsC$32.32 million05/16/2024C$0.08C$0.08-6.25%C$0.09C$0.081.73 million shsC$30.30 million05/15/2024C$0.09C$0.08-5.88%C$0.09C$0.08670,679 shsC$32.32 million05/14/2024C$0.08C$0.09+6.25%C$0.09C$0.08338,426 shsC$34.34 million05/13/2024C$0.08C$0.08C$0.09C$0.08140,091 shsC$32.32 million05/10/2024C$0.08C$0.08C$0.09C$0.0823,872 shsC$32.32 million Get the Latest News and Ratings for LABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024C$0.09C$0.08-5.88%C$0.09C$0.0864,620 shsC$32.32 million05/08/2024C$0.08C$0.09+6.25%C$0.09C$0.0824,203 shsC$34.34 million05/07/2024C$0.09C$0.08-11.11%C$0.09C$0.0899,267 shsC$32.32 million05/06/2024C$0.09C$0.09+5.88%C$0.09C$0.0888,606 shsC$36.36 million05/03/2024C$0.08C$0.09+6.25%C$0.09C$0.0877,416 shsC$34.34 million05/02/2024C$0.09C$0.08-5.88%C$0.09C$0.0887,695 shsC$32.32 million05/01/2024C$0.10C$0.09-10.53%C$0.10C$0.09308,437 shsC$34.34 million04/30/2024C$0.08C$0.10+18.75%C$0.10C$0.08575,375 shsC$38.12 million04/29/2024C$0.08C$0.08C$0.08C$0.0866,419 shsC$32.10 million04/26/2024C$0.08C$0.08C$0.08C$0.08228,800 shsC$32.10 million04/25/2024C$0.08C$0.08C$0.09C$0.0851,440 shsC$32.10 million04/24/2024C$0.08C$0.08+6.67%C$0.09C$0.08440,300 shsC$32.10 million04/23/2024C$0.08C$0.08C$0.08C$0.08118,919 shsC$30.10 million04/22/2024C$0.08C$0.08-6.25%C$0.08C$0.08280,373 shsC$30.10 million04/19/2024C$0.08C$0.08+6.67%C$0.08C$0.0832,329 shsC$32.10 million04/18/2024C$0.08C$0.08-6.25%C$0.08C$0.08120,810 shsC$30.10 million04/17/2024C$0.08C$0.08C$0.08C$0.0841,580 shsC$32.10 million04/16/2024C$0.08C$0.08C$0.09C$0.08293,039 shsC$32.10 million04/15/2024C$0.08C$0.08C$0.09C$0.08499,211 shsC$32.10 million04/12/2024C$0.09C$0.08-5.88%C$0.09C$0.0842,082 shsC$32.10 million04/11/2024C$0.08C$0.09+6.25%C$0.09C$0.08229,700 shsC$34.11 million04/10/2024C$0.09C$0.08-5.88%C$0.09C$0.08151,991 shsC$32.10 million04/09/2024C$0.09C$0.09C$0.09C$0.08215,559 shsC$34.11 million04/08/2024C$0.09C$0.09C$0.09C$0.09285,982 shsC$34.11 million04/05/2024C$0.09C$0.09C$0.09C$0.09163,408 shsC$34.11 million04/04/2024C$0.09C$0.09C$0.09C$0.08382,716 shsC$34.11 million04/03/2024C$0.08C$0.09+6.25%C$0.09C$0.08267,272 shsC$34.11 million04/02/2024C$0.09C$0.08-5.88%C$0.09C$0.0885,542 shsC$32.10 million04/01/2024C$0.08C$0.09+6.25%C$0.09C$0.08171,969 shsC$34.11 million03/29/2024C$0.08C$0.08C$0.09C$0.08378,753 shsC$32.10 million03/28/2024C$0.09C$0.08-11.11%C$0.09C$0.08378,753 shsC$32.10 million03/27/2024C$0.10C$0.09-5.26%C$0.10C$0.09641,768 shsC$36.12 million03/26/2024C$0.09C$0.10+11.76%C$0.10C$0.091.28 million shsC$38.12 million03/25/2024C$0.09C$0.09C$0.09C$0.091.10 million shsC$34.11 millionShocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company03/22/2024C$0.07C$0.09+30.77%C$0.09C$0.072.12 million shsC$34.11 million03/21/2024C$0.07C$0.07C$0.07C$0.0743,355 shsC$26.08 million03/20/2024C$0.07C$0.07-7.14%C$0.07C$0.07251,929 shsC$26.08 million03/19/2024C$0.07C$0.07C$0.07C$0.0718,910 shsC$28.09 million03/18/2024C$0.07C$0.07C$0.07C$0.0712,806 shsC$28.09 million03/15/2024C$0.07C$0.07+7.69%C$0.07C$0.0772,291 shsC$28.09 million03/14/2024C$0.07C$0.07C$0.07C$0.07134,628 shsC$26.08 million03/13/2024C$0.07C$0.07C$0.07C$0.0781,176 shsC$26.08 million03/12/2024C$0.07C$0.07C$0.07C$0.0743,318 shsC$26.08 million03/11/2024C$0.07C$0.07-7.14%C$0.07C$0.0714,700 shsC$26.08 million03/08/2024C$0.07C$0.07+7.69%C$0.07C$0.0711,661 shsC$28.09 million03/07/2024C$0.07C$0.07-7.14%C$0.07C$0.07192,892 shsC$26.08 million03/06/2024C$0.07C$0.07+7.69%C$0.07C$0.0787,888 shsC$28.09 million03/05/2024C$0.07C$0.07-7.14%C$0.08C$0.07167,001 shsC$26.08 million03/04/2024C$0.07C$0.07C$0.07C$0.07293,481 shsC$28.09 million03/01/2024C$0.07C$0.07C$0.07C$0.07115,967 shsC$28.09 million02/29/2024C$0.07C$0.07+7.69%C$0.07C$0.07176,134 shsC$28.09 million02/28/2024C$0.07C$0.07-7.14%C$0.07C$0.0794,646 shsC$26.08 million02/27/2024C$0.07C$0.07+7.69%C$0.07C$0.07164,000 shsC$28.09 million02/26/2024C$0.07C$0.07-7.14%C$0.07C$0.0759,606 shsC$26.08 million02/23/2024C$0.07C$0.07+7.69%C$0.07C$0.074,367 shsC$28.09 million02/22/2024C$0.07C$0.07-7.14%C$0.07C$0.0753,372 shsC$26.08 million02/21/2024C$0.07C$0.07C$0.07C$0.0795,140 shsC$28.09 million02/20/2024C$0.07C$0.07C$0.07C$0.07317,903 shsC$28.09 million02/19/2024C$0.07C$0.07C$0.07C$0.0725,056 shsC$28.09 million Related Companies: Charlotte's Web Stock Chart Medexus Pharmaceuticals Stock Chart Decibel Cannabis Stock Chart Indiva Stock Chart Medicure Stock Chart Willow Biosciences Stock Chart Valeo Pharma Stock Chart BioSyent Stock Chart HLS Therapeutics Stock Chart IBEX Technologies Stock Chart Receive LABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:LABS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.